Cognito Therapeutics has filed a notice of an exempt offering of securities to raise $60,032,626.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Cognito Therapeutics is raising up to $60,032,626.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Brent Vaughan played a…
